FDA Approves First-in-Class Aldosterone Synthase Inhibitor for Uncontrolled Hypertension Dr Kartikeya Kohli19 May 2026 10:00 AM ISTThe FDA has approved baxdrostat (Baxfendy), the first oral aldosterone synthase inhibitor, for adults with uncontrolled hypertension as add-on therapy...
Higher dietary soy and legume intake linked to lower high BP risk, suggests research Dr. Kamal Kant Kohli15 May 2026 8:00 AM ISTA higher dietary intake of soy and legumes is linked to a lower risk of high blood pressure, finds a pooled data analysis of the available evidence,...
Combined exercise and HIIT linked to significant falls in blood pressure over 24 Hours: Study Dr. Kamal Kant Kohli13 May 2026 10:30 AM ISTAerobic and resistance training combined, and high intensity interval training (HIIT), are associated with significant reductions in blood pressure...
Lp(a) ≥50 mg/dL: An Emerging Determinant of Valvular Risk and Evolving Role of Aspirin- Dr Rajesh B. Bhurkunde Dr. Rajesh B. Bhurkunde6 May 2026 10:19 AM ISTThe pattern of valvular heart disease in India is shifting. Degenerative tricuspid aortic stenosis now accounts for 58.1% of acquired isolated aortic...
New study predicts real-world impact of using smartwatches to detect undiagnosed high BP Dr Kartikeya Kohli28 April 2026 8:30 PM ISTIn September 2025, the U.S. Food and Drug Administration cleared the Apple Watch Hypertension Notifications Feature, a cuffless tool that uses the...
Yoga practice could reduce blood pressure in people with obesity, finds research Dr. Kamal Kant Kohli26 April 2026 8:15 PM ISTPracticing yoga could help people with overweight or obesity improve their cardiometabolic health, according to a study published April 22 in the...
Clopidogrel for Long-Term Therapy After PCI, Findings from 10-Year HOST-EXAM: ACC 2026 Update Deeksha Bhandari25 April 2026 12:00 PM ISTHOST-EXAM trial, a landmark study recently released at the ACC 2026. The trial sought to determine the effectiveness of Clopidogrel...
Low-Dose Triple Combination Pill Effective for Hypertension Control, finds study Jacinthlyn Sylvia20 April 2026 10:45 AM ISTA study published in the Journal of the American College of Cardiology found that a single-pill low-dose combination of amlodipine, losartan, and...
SGLT2 Inhibitors exhibit greater BP lowering effect compared to DPP-4 Inhibitors: Study Jacinthlyn Sylvia16 April 2026 9:00 PM ISTA recent study published in the International Journal of Molecular Sciences revealed that patients initiating sodium-glucose cotransporter 2 (SGLT2)...
Sotatercept shows promise for uncommon type of pulmonary hypertension linked to HF with preserved ejection fraction: Study Dr. Kamal Kant Kohli9 April 2026 8:45 PM ISTPatients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced...
With help from AI, eye images offer window into cardiovascular risk: Study Dr. Kamal Kant Kohli1 April 2026 8:45 PM ISTA new system that uses artificial intelligence (AI) to assess cardiovascular risk based on images of the eye captured during eye exams demonstrated...
Integrating Dapagliflozin and Sitagliptin FDC for Optimizing Outcomes in Type-2 Diabetes with Cardiometabolic-Based Chronic Disease (CMBCD) patients - Dr Kaushik Biswas Dr. Kaushik Biswas28 March 2026 10:27 AM ISTIntroduction India's T2D population carries a substantial burden-nearly two-thirds of individuals with T2D are overweight or obese, indicating a...
